Cardiac high-energy phosphate metabolism alters with age as studied in 196 healthy males with the help of 31-phosphorus 2-dimensional chemical shift imaging

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Esterhammer, Regina ^a   Klug, Gert ^a   Wolf, Christian ^a,b   Mayr, Agnes ^a   Reinstadler, Sebastian ^a   Feistritzer, Hans Josef ^a   Metzler, Bernhard ^a   Schocke, Michael F H ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Department of Radiology District Hospital Reutte   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BETA ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; GLUCOSE; PHOSPHORUS 31; UNCLASSIFIED DRUG; PHOSPHORUS;

ADULT; AEROBIC METABOLISM; AGE DISTRIBUTION; AGED; AGING; ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ECHOCARDIOGRAPHY; GLUCOSE BLOOD LEVEL; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MITOCHONDRION; HEART MUSCLE METABOLISM; HIGH ENERGY PHOSPHATE; HUMAN; HUMAN EXPERIMENT; IMAGING; MALE; MITOCHONDRIAL RESPIRATION; NORMAL HUMAN; PHOSPHATE METABOLISM; SYSTOLIC BLOOD PRESSURE; TWO DIMENSIONAL CHEMICAL SHIFT IMAGING; BIOSYNTHESIS; BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART MUSCLE; HEART STROKE VOLUME; HEART VENTRICLE; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE PHOSPHORYLATION; PHYSIOLOGY;

ADENOSINE TRIPHOSPHATE; ADULT; AGED; AGING; BLOOD PRESSURE; ECHOCARDIOGRAPHY, DOPPLER; GLUCOSE; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; OXIDATIVE PHOSPHORYLATION; PHOSPHOCREATINE; PHOSPHORUS; PHOSPHORUS ISOTOPES; STROKE VOLUME;

EID: 84903137220     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097368     Document Type: Article

References (60)

1. Edwards LM, Ashrafian H, Korzeniewski B (2011) In silico studies on the sensitivity of myocardial PCr/ATP to changes in mitochondrial enzyme activity and oxygen concentration. Mol Biosyst 7: 3335-3342.
2. Saks V, Dzeja P, Schlattner U, Vendelin M, Terzic A, et al. (2006) Cardiac system bioenergetics: metabolic basis of the Frank-Starling law. J Physiol 571: 253-273.
3. Flaherty JT, Weisfeldt ML, Bulkley BH, Gardner TJ, Gott VL, et al. (1982) Mechanisms of ischemic myocardial cell damage assessed by phosphorus-31 nuclear magnetic resonance. Circulation 65: 561-570.
4. Farrall AJ, Thompson RT, Wisenberg G, Campbell CM, Drost DJ (1997) Myocardial infarction in a canine model monitored by two-dimensional 31P chemical shift spectroscopic imaging. Magn Reson Med 38: 577-584.
5. Bottomley PA, Herfkens RJ, Smith LS, Bashore TM (1987) Altered phosphate metabolism in myocardial infarction: P-31 MR spectroscopy. Radiology 165: 703-707.
6. Weiss RG, Bottomley PA, Hardy CJ, Gerstenblith G (1990) Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease. N Engl J Med 323: 1593-1600.
7. Beer M, Machann W, Sandstede J, Buchner S, Lipke C, et al. (2007) Energetic differences between viable and non-viable myocardium in patients with recent myocardial infarction are not an effect of differences in wall thinning- a multivoxel (31)P-MR-spectroscopy and MRI study. Eur Radiol 17: 1275-1283.
8. Neubauer S, Horn M, Cramer M, Harre K, Newell JB, et al. (1997) Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 96: 2190-2196.
9. Metzler B, Schocke MFH, Steinboeck P, Wolf C, Judmaier W, et al. (2002) Decreased high-energy phosphate ratios in the myocardium of men with diabetes mellitus type I. J Cardiovasc Magn Reson 4: 493-502.
10. Scheuermann-Freestone M, Madsen PL, Manners D, Blamire AM, Buckingham RE, et al. (2003) Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation 107: 3040-3046.
11. Schocke MF, Martinek M, Kremser C, Wolf C, Steinboeck P, et al. (2003) 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors improve myocardial high-energy phosphate metabolism in men. J Cardiovasc Magn Reson 5: 595-602.
12. Crilley JG, Boehm EA, Rajagopalan B, Blamire AM, Styles P, et al. (2000) Magnetic resonance spectroscopy evidence of abnormal cardiac energetics in Xp21 muscular dystrophy. J Am Coll Cardiol 36: 1953-1958.
13. Lodi R, Rajagopalan B, Schapira AHV, Cooper JM (2003) Cardiac bioenergetics in Friedreich's ataxia. Ann Neurol 54: 552; author reply 552-3.
14. Lodi R, Rajagopalan B, Blamire AM, Crilley JG, Styles P, et al. (2004) Abnormal cardiac energetics in patients carrying the A3243G mtDNA mutation measured in vivo using phosphorus MR spectroscopy. Biochim Biophys Acta 1657: 146-150.
15. Schneider-Gold C, Beer M, Kostler H, Buchner S, Sandstede J, et al. (2004) Cardiac and skeletal muscle involvement in myotonic dystrophy type 2 (DM2): a quantitative 31P-MRS and MRI study. Muscle Nerve 30: 636-644.
16. Schocke MFH, Zoller H, Vogel W, Wolf C, Kremser C, et al. (2004) Cardiac phosphorus-31 two-dimensional chemical shift imaging in patients with hereditary hemochromatosis. Magn Reson Imaging 22: 515-521.
17. Wolf C, Boesch S, Metzler B, Weirich-Schwaiger H, Trieb T, et al. (2008) Phosphorus-31 two-dimensional chemical shift imaging in the myocardium of patients with late onset of Friedreich ataxia. Mol Imaging Biol 10: 24-29.
18. Klug G, Zwick RH, Frick M, Wolf C, Schocke MFH, et al. (2007) Impact of exercise capacity on myocardial high-energy phosphate metabolism. Int J Sports Med 28: 667-672.
19. Frick M, Klug G, Zwick RH, Schocke MF, Jaschke W, et al. (2011) Different effects of rosuvastatin and simvastatin on myocardial high-energy phosphate metabolism. Int J Cardiol 148: 112-114.
20. Klug G, Zwick RH, Mayr A, Schocke MF, Steinboeck P, et al. (2011) Correlation of cardiovascular risk scores with myocardial high-energy phosphate metabolism. Int J Cardiol 150: 208-210.
21. Schocke MFH, Metzler B, Wolf C, Steinboeck P, Kremser C, et al. (2003) Impact of aging on cardiac high-energy phosphate metabolism determined by phosphorus-31 2-dimensional chemical shift imaging (31P 2D CSI). Magn Reson Imaging 21: 553-559.
22. Okada M, Mitsunami K, Inubushi T, Kinoshita M (1998) Influence of aging or left ventricular hypertrophy on the human heart: contents of phosphorus metabolites measured by 31P MRS. Magn Reson Med 39: 772-782.
23. Kostler H, Landschutz W, Koeppe S, Seyfarth T, Lipke C, et al. (2006) Age and gender dependence of human cardiac phosphorus metabolites determined by SLOOP 31P MR spectroscopy. Magn Reson Med 56: 907-911.
24. Hollingsworth KG, Blamire AM, Keavney BD, Macgowan GA (2012) Left ventricular torsion, energetics, and diastolic function in normal human aging. Am J Physiol Heart Circ Physiol 302: H885-92.
25. Burtscher M (2013) Exercise limitations by the oxygen delivery and utilization systems in aging and disease: coordinated adaptation and deadaptation of the lung-heart muscle axis - a mini-review. Gerontology 59: 289-296.
26. Judge S, Leeuwenburgh C (2007) Cardiac mitochondrial bioenergetics, oxidative stress, and aging. Am J Physiol Cell Physiol 292: C1983-92.
27. Terman A, Brunk UT (2005) Autophagy in cardiac myocyte homeostasis, aging, and pathology. Cardiovasc Res 68: 355-365.
28. Dutta D, Calvani R, Bernabei R, Leeuwenburgh C, Marzetti E (2012) Contribution of impaired mitochondrial autophagy to cardiac aging: mechanisms and therapeutic opportunities. Circ Res 110: 1125-1138.
29. Kitzman DW, Sheikh KH, Beere PA, Philips JL, Higginbotham MB (1991) Age-related alterations of Doppler left ventricular filling indexes in normal subjects are independent of left ventricular mass, heart rate, contractility and loading conditions. J Am Coll Cardiol 18: 1243-1250.
30. de Souza RR (2002) Aging of myocardial collagen. Biogerontology 3: 325-335.
31. Nikitin NP, Loh PH, de Silva R, Witte KKA, Lukaschuk EI, et al. (2006) Left ventricular morphology, global and longitudinal function in normal older individuals: a cardiac magnetic resonance study. Int J Cardiol, 108: 76-83.
32. Nageswara Rao BD, Cohn M (1981) 31P NMR of enzyme-bound substrates of rabbit muscle creatine kinase. Equilibrium constants, interconversion rates, and NMR parameters of enzyme-bound complexes. J Biol Chem 256: 1716-1721.
33. Tanokura M, Ebashi S (1993) Complexes of myosin subfragment 1 with pyrophosphate and with adenosine diphosphate as studied by phosphorus-31 nuclear magnetic resonance. J Biochem 113: 19-21.
34. Stubbs M, Van den Boogaart A, Bashford CL, Miranda PM, Rodrigues LM, et al. (1996) 31P-magnetic resonance spectroscopy studies of nucleated and non-nucleated erythrocytes; time domain data analysis (VARPRO) incorporating prior knowledge can give information on the binding of ADP. Biochim Biophys Acta 1291: 143-148.
35. Suzuki Y, Tanokura M, Shimizu T (1998) Evidence for existence of multiple conformations of kinesin and ncd motor domains in solution revealed by 31P-NMR of the tightly bound ADP. Eur J Biochem 257: 466-471.
36. Jacobus WE, Moreadith RW, Vandegaer KM (1982) Mitochondrial respiratory control. Evidence against the regulation of respiration by extramitochondrial phosphorylation potentials or by [ATP]/[ADP] ratios. J Biol Chem 257: 2397-2402.
37. Petersen A, Kristensen SR, Jacobsen JP, Horder M (1990) 31P-NMR measurements of ATP, ADP, 2,3-diphosphoglycerate and Mg2+ in human erythrocytes. Biochim Biophys Acta 1035: 169-174.
38. Saks VA, Kuznetsov AV, Vendelin M, Guerrero K, Kay L, et al. (2004) Functional coupling as a basic mechanism of feedback regulation of cardiac energy metabolism. Mol Cell Biochem 256-257: 185-199.
39. Robergs RA, Ghiasvand F, Parker D (2004) Biochemistry of exercise-induced metabolic acidosis. Am J Physiol Regul Integr Comp Physiol 287: R502-16.
40. Dzeja PP, Hoyer K, Tian R, Zhang S, Nemutlu E, et al. (2011) Rearrangement of energetic and substrate utilization networks compensate for chronic myocardial creatine kinase deficiency. J Physiol 589: 5193-5211.
41. Bak MI, Wei JY, Ingwall JS (1998) Interaction of hypoxia and aging in the heart: analysis of high energy phosphate content. J Mol Cell Cardiol 30: 661-672.
42. Saupe KW, Spindler M, Hopkins JC, Shen W, Ingwall JS (2000) Kinetic, thermodynamic, and developmental consequences of deleting creatine kinase isoenzymes from the heart. Reaction kinetics of the creatine kinase isoenzymes in the intact heart. J Biol Chem 275: 19742-19746.
43. Harman D (2006) Free radical theory of aging: an update: increasing the functional life span. Ann N Y Acad Sci 1067: 10-21.
44. Ingwall JS (2004) Transgenesis and cardiac energetics: new insights into cardiac metabolism. J Mol Cell Cardiol 37: 613-623.
45. Nahrendorf M, Spindler M, Hu K, Bauer L, Ritter O, et al. (2005) Creatine kinase knockout mice show left ventricular hypertrophy and dilatation, but unaltered remodeling post-myocardial infarction. Cardiovasc Res 65: 419-427.
46. Wallis J, Lygate CA, Fischer A, ten Hove M, Schneider JE, et al. (2005) Supranormal myocardial creatine and phosphocreatine concentrations lead to cardiac hypertrophy and heart failure: insights from creatine transporter-overexpressing transgenic mice. Circulation 112: 3131-3139.
47. Hacker TA, McKiernan SH, Douglas PS, Wanagat J, Aiken JM (2006) Age-related changes in cardiac structure and function in Fischer 344 x Brown Norway hybrid rats. Am J Physiol Heart Circ Physiol 290: H304-11.
48. Hees PS, Fleg JL, Dong S, Shapiro EP (2004) MRI and echocardiographic assessment of the diastolic dysfunction of normal aging: altered LV pressure decline or load?. Am J Physiol Heart Circ Physiol 286: H782-8.
49. Lakatta EG, Sollott SJ (2002) Perspectives on mammalian cardiovascular aging: humans to molecules. Comp Biochem Physiol A Mol Integr Physiol 132: 699-721.
50. Fleg JL, Strait J (2012) Age-associated changes in cardiovascular structure and function: a fertile milieu for future disease. Heart Fail Rev 17: 545-554.
51. Freeman DM, Hurd R (1997) Decoupling: theory and practice. II. State of the art: in vivo applications of decoupling. NMR Biomed 10: 381-393.
52. Jung WI, Sieverding L, Breuer J, Hoess T, Widmaier S, et al. (1998) 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 97: 2536-2542.
53. van Dobbenburgh JO, Lekkerkerk C, van Echteld CJ, de Beer R (1994) Saturation correction in human cardiac 31P MR spectroscopy at 1.5 T. NMR Biomed 7: 218-224.
54. Gabr RE, Ouwerkerk R, Bottomley PA (2006) Quantifying in vivo MR spectra with circles. J Magn Reson 179: 152-163.
55. Hudsmith LE, Neubauer S (2009) Magnetic resonance spectroscopy in myocardial disease. JACC Cardiovasc Imaging 2: 87-96.
56. Bottomley PA (1994) MR spectroscopy of the human heart: the status and the challenges. Radiology 191: 593-612.
57. Judge S, Jang YM, Smith A, Selman C, Phillips T, et al. (2005) Exercise by lifelong voluntary wheel running reduces subsarcolemmal and interfibrillar mitochondrial hydrogen peroxide production in the heart. Am J Physiol Regul Integr Comp Physiol 289: R1564-72.
58. Ferket BS, van Kempen BJH, Hunink MGM, Agarwal I, Kavousi M, et al. (2014) Predictive value of updating framingham risk scores with novel risk markers in the U.S. general population. PLoS ONE 9: e88312.
59. Dahlof B (2010) Cardiovascular disease risk factors: epidemiology and risk assessment. Am J Cardiol 105: 3A-9A.
60. R Development Core Team (2008) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria.